Home › Research › Tau biomarkers
Different cerebrospinal fluid levels of Alzheimer-type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis
Luo X, Shi H, Hou L, Zhong X, Chen X, Zhang Y, Zheng D, Tan Y et al.. European journal of neurology, 2015-02-23
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background and purpose Neurosyphilis is a neurological disease that involves infection of the central nervous system with Treponema pallidum. With increases in unsafe sexual behaviour, syphilis has re-emerged worldwide. To explore the amyloid and tau metabolism in neurosyphilis patients in different stages, the levels of Alzheimer-type biomarkers in general paresis (GP) and asymptomatic neurosyphilis (ANS) patients in comparison to patients with Alzheimer's disease (AD) and normal controls (NCs) were investigated.
What this study adds
Evidence grade: Low
The record lists 44 participants. This study compared Alzheimer-type biomarkers in the spinal fluid of people with general paresis, asymptomatic neurosyphilis, Alzheimer's disease, and normal controls. It found different levels of amyloid-42 between these groups, but it is about diagnosis, not treatment or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Luo, X., Shi, H., Hou, L., Zhong, X., Chen, X., Zhang, Y., et al. (2015). Different cerebrospinal fluid levels of Alzheimer-type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis. European journal of neurology. https://doi.org/10.1111/ene.12680
Vancouver
Luo X, Shi H, Hou L, Zhong X, Chen X, Zhang Y, et al. Different cerebrospinal fluid levels of Alzheimer-type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis. European journal of neurology. 2015. doi:10.1111/ene.12680. PMID: 25707998.
BibTeX
@article{luo2015-25707998,
author = {Luo, X. and Shi, H. and Hou, L. and Zhong, X. and Chen, X. and Zhang, Y. and Zheng, D. and Tan, Y. and others},
title = {{Different cerebrospinal fluid levels of Alzheimer-type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis}},
journal = {European journal of neurology},
year = {2015},
doi = {10.1111/ene.12680},
pmid = {25707998},
url = {https://doi.org/10.1111/ene.12680}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- With increases in unsafe sexual behaviour, syphilis has re-emerged worldwide.
- To explore the amyloid and tau metabolism in neurosyphilis patients in different stages, the levels of Alzheimer-type biomarkers in general paresis (GP) and asymptomatic neurosyphilis (ANS) patients in comparison to patients with Alzheimer's disease (AD) and normal controls (NCs) were investigated.
- Methods β-amyloid peptide 1-42 (Aβ42) and Aβ 1-40 (Aβ40), tau hyperphosphorylated at threonine 181 (p-tau181) and total tau (t-tau) in cerebrospinal fluid (CSF) were measured by enzyme-linked immunosorbent assay kits in 44 patients with GP, 10 patients with ANS, 45 patients with AD and 39 NCs.
- Results Alzheimer's disease patients had lower CSF Aβ42 levels combined with higher CSF t-tau and p-tau181 levels than other groups (all P Conclusions Our research has demonstrated that GP, ANS and AD patients are characterized by distinct patterns of the CSF biomarkers Aβ and tau.
Why it matters
This study compared Alzheimer-type biomarkers in the spinal fluid of people with general paresis, asymptomatic neurosyphilis, Alzheimer's disease, and normal controls. It found different levels of amyloid-42 between these groups, but it is about diagnosis, not treatment or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants44
- Evidence strengthLow
How this study scored 36/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (European journal of neurology) |
| Journal's citation record | 2 / 4 | European Journal of Neurology: journal h-index 181 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2015 — within 20 year(s) of the newest study here |
| Sample size | 1 / 4 | 44 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 15 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.2 citations a year over 13 year(s) since 2015 |
| Impact for its field and year | 1 / 6 | Cited 0.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Yuping Ning: h-index 48 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Guangzhou Medical University: institution h-index 468 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 25707998) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 36 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.